Format

Send to

Choose Destination
Adv Funct Mater. 2013 Aug 1;23(36):4621-4628.

Inflammatory cytokines presented from polymer matrices differentially generate and activate DCs in situ.

Author information

1
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA.
2
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA ; School of Engineering and Applied Sciences, Harvard University, Cambridge, MA.

Abstract

During infection, inflammatory cytokines mobilize and activate dendritic cells (DCs), which are essential for efficacious T cell priming and immune responses that clear the infection. Here we designed macroporous poly(lactide-co-glycolide) (PLG) matrices to release the inflammatory cytokines GM-CSF, Flt3L and CCL20, in order to mimic infection-induced DC recruitment. We then tested the ability of these infection mimics to function as cancer vaccines via induction of specific, anti-tumor T cell responses. All vaccine systems tested were able to confer specific anti-tumor T cell responses and longterm survival in a therapeutic, B16-F10 melanoma model. However, GM-CSF and Flt3L vaccines resulted in similar survival rates, and outperformed CCL20 loaded scaffolds, even though they had differential effects on DC recruitment and generation. GM-CSF signaling was identified as the most potent chemotactic factor for conventional DCs and significantly enhanced surface expression of MHC(II) and CD86(+), which are utilized for priming T cell immunity. In contrast, Flt3L vaccines led to greater numbers of plasmacytoid DCs (pDCs), correlating with increased levels of T cell priming cytokines that amplify T cell responses. These results demonstrate that 3D polymer matrices modified to present inflammatory cytokines may be utilized to effectively mobilize and activate different DC subsets in vivo for immunotherapy.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center